Electrophysiology Mapping and Ablation Devices – Market Insights – Asia Pacific (Supplemental)

Although the global COVID-19 pandemic negatively impacted the Asia Pacific EP mapping and ablation device market in 2020, the market has shown strong recovery and will resume prepandemic growth trends in the near term. Going forward, the Asia Pacific EP mapping and ablation device market will expand rapidly, supported by rising AF treatment volumes, an expanding patient pool, improving access to healthcare, and the emergence of newer, premium-priced devices, although cost constraints and a challenging reimbursement environment will hinder the pace of market expansion to some extent.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for EP mapping and ablation devices in Asia Pacific from 2019 through 2032.

Table of contents

Electrophysiology Mapping and Ablation Devices - Market Insights - Asia Pacific (Supplemental)

K Prasanna Bhat

K Prasanna Bhat is an associate healthcare research and data analyst on the Cardiovascular Medtech Insights team at Clarivate. Prasanna holds a Bachelor’s degree in Bachelor of Pharmacy and Master’s degree in Pharmaceutical administration from Manipal College of Pharmaceutical Sciences.

Contact sales Login to access report

Back to all Medtech Insights reports